| Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer S Shu, CY Lin, HH He, RM Witwicki, DP Tabassum, JM Roberts, ... Nature 529 (7586), 413-417, 2016 | 644 | 2016 |
| Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11. 2 locus S Jacquemont, A Reymond, F Zufferey, L Harewood, RG Walters, ... Nature 478 (7367), 97-102, 2011 | 556 | 2011 |
| Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcription H Kilpinen, SM Waszak, AR Gschwind, SK Raghav, RM Witwicki, A Orioli, ... Science 342 (6159), 744-747, 2013 | 410 | 2013 |
| A 600 kb deletion syndrome at 16p11. 2 leads to energy imbalance and neuropsychiatric disorders F Zufferey, EH Sherr, ND Beckmann, E Hanson, AM Maillard, L Hippolyte, ... Journal of medical genetics 49 (10), 660-668, 2012 | 331 | 2012 |
| Population variation and genetic control of modular chromatin architecture in humans SM Waszak, O Delaneau, AR Gschwind, H Kilpinen, SK Raghav, ... Cell 162 (5), 1039-1050, 2015 | 247 | 2015 |
| Opposite Effects of Mn2+ and Zn2+ on PsaR-Mediated Expression of the Virulence Genes pcpA, prtA, and psaBCA of Streptococcus pneumoniae TG Kloosterman, RM Witwicki, MM van der Kooi-Pol, JJE Bijlsma, ... Journal of bacteriology 190 (15), 5382-5393, 2008 | 93 | 2008 |
| Genes with monoallelic expression contribute disproportionately to genetic diversity in humans V Savova, S Chun, M Sohail, RB McCole, R Witwicki, L Gai, TL Lenz, ... Nature genetics 48 (3), 231-237, 2016 | 86 | 2016 |
| A potential contributory role for ciliary dysfunction in the 16p11. 2 600 kb BP4-BP5 pathology E Migliavacca, C Golzio, K Männik, I Blumenthal, EC Oh, L Harewood, ... The American Journal of Human Genetics 96 (5), 784-796, 2015 | 72 | 2015 |
| YAP-mediated recruitment of YY1 and EZH2 represses transcription of key cell-cycle regulators S Hoxha, A Shepard, S Troutman, H Diao, JR Doherty, M Janiszewska, ... Cancer research 80 (12), 2512-2522, 2020 | 60 | 2020 |
| TRPS1 is a lineage-specific transcriptional dependency in breast cancer RM Witwicki, MB Ekram, X Qiu, M Janiszewska, S Shu, M Kwon, A Trinh, ... Cell reports 25 (5), 1255-1267. e5, 2018 | 59 | 2018 |
| Structural variation-associated expression changes are paralleled by chromatin architecture modifications N Gheldof, RM Witwicki, E Migliavacca, M Leleu, G Didelot, L Harewood, ... PLoS One 8 (11), e79973, 2013 | 45 | 2013 |
| Identification and removal of low-complexity sites in allele-specific analysis of ChIP-seq data SM Waszak, H Kilpinen, AR Gschwind, A Orioli, SK Raghav, RM Witwicki, ... Bioinformatics 30 (2), 165-171, 2014 | 14 | 2014 |
| Heterogeneity and transcriptional drivers of triple-negative breast cancer B Jovanović, D Temko, LE Stevens, M Seehawer, A Fassl, K Murphy, ... Cell reports 42 (12), 2023 | 8 | 2023 |
| Abstract B16: Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer S Shu, C Lin, HH He, R Witwicki, J Roberts, D Tabassum, Y Liang, ... Molecular Cancer Research 14 (2_Supplement), B16-B16, 2016 | | 2016 |
| Copy number variation and chromatin structure RM Witwicki Université de Lausanne, Faculté de biologie et médecine, 2012 | | 2012 |
| 898 ЕА Никитина и др. N Gheldof, R Witwicki, E Migliavacca, M Leleu, G Didelot, GC Girdler, ... Russ. J. Genet 51, 582-590, 0 | | |
